|
|
|
|
LEADER |
00000cam a2200000 a 4500 |
001 |
2966919 |
003 |
ICU |
005 |
20030526101700.0 |
008 |
980318s1998 sz a 001 0 eng d |
020 |
|
|
|a 3805566409
|
035 |
|
|
|a (OCoLC)38738035
|
040 |
|
|
|a FIP
|b fre
|c FIP
|d AGL
|d IWA
|d OrLoB-B
|d OCoLC
|
049 |
|
|
|a CGUA
|
070 |
0 |
|
|a QR180.3.D4
|b no.92
|
072 |
|
0 |
|a X300
|a X380
|
090 |
|
|
|a QR189
|b M63x, 1998
|
096 |
|
|
|a QH 307
|f DEV
|
245 |
0 |
0 |
|a Modulation of the immune response to vaccine antigens :
|b University of Bergen, Norway, june 18-21, 1996 /
|c volume editors, Fred Brown...[et al.]
|
260 |
|
|
|a Basel :
|b Karger,
|c 1998.
|
300 |
|
|
|a xii, 372 p. :
|b ill. ;
|c 24 cm.
|
336 |
|
|
|a text
|b txt
|2 rdacontent
|0 http://id.loc.gov/vocabulary/contentTypes/txt
|
337 |
|
|
|a unmediated
|b n
|2 rdamedia
|0 http://id.loc.gov/vocabulary/mediaTypes/n
|
338 |
|
|
|a volume
|b nc
|2 rdacarrier
|0 http://id.loc.gov/vocabulary/carriers/nc
|
440 |
|
0 |
|a Developments in biological standardization
|v 92.
|
504 |
|
|
|a Bibliogr. Index.
|
505 |
0 |
0 |
|t The Mode of Action of Immunological Adjuvants /
|r A. C. Allison --
|t Will Adjuvants be Needed for Vaccines of the Future? /
|r R. Bomford --
|t Adjuvants and Delivery Systems for Viral Vaccines - Mechanisms and Potential /
|r R. Jennings, J. R. Simms and A. W. Heath --
|t Rapporteur's Summary /
|r K. Mills --
|t Iscom, a Delivery System for Parenteral and Mucosal Vaccination /
|r B. Morein, M. Villacres-Eriksson and K. Lovgren-Bengisson --
|t QS-21 and QS-7: Purified Saponin Adjuvants /
|r C. Kensil, J.-Y. Wu and C. A. Anderson [et al.] --
|t Induction of Virus-Specific Immunity by Iscoms /
|r A. D. M. E. Osterhaus and G. F. Rimmelzwaan --
|t Rapporteur's Summary /
|r A. C. Allison --
|t Biodegradable Polymer Microspheres as Vaccine Adjuvants and Delivery Systems /
|r R. K. Gupta, A.-C. Chang and G. R. Siber --
|t PCPP as a Parenteral Adjuvant for Diverse Antigens /
|r L. G. Payne, G. Van Nest and G. L. Barchfeld [et al.] --
|t Rapporteur's Summary /
|r J. Holmgren and R. K. Gupta --
|t Cellular and Molecular Mechanisms for Induction of Mucosal Immunity /
|r P. Brandtzaeg, I. N. Farstad and G. Haraldsen [et al.] --
|t Lipidation as a Novel Approach to Mucosal Immunization /
|r J. P. Tam, A. L. Mora and C. Rao --
|t Systemic Immunization with Conserved Pilus-Associated Adhesins Protects Against Mucosal Infections /
|r S. Palaszynski, J. Pinkner and S. Leath [et al.] --
|t Adjuvant Effect of Non-Toxic Mutants of E. Coli Heat-Labile Enterotoxin Following Intranasal, Oral and Intravaginal Immunization /
|r M. T. De Magistris, M. Pizza and G. Douce [et al.] --
|t Towards a Nasal Vaccine Against Meningococcal Disease, and Prospects for its Use as a Mucosal Adjuvant /
|r B. Haneberg, R. Dalseg and F. Oftung [et al.] --
|t Rapporteurs' Summary /
|r P. Brandtzaeg and T. Lehner --
|t The Potential of Retro-Inverso Peptides as Synthetic Vaccines /
|r M. H. V. Van Regenmortel, G. Guichard and N. Benkirane [et al.] --
|t Protective Immunity to Intracellular Parasites - A Focus for Vaccine Research and a Challenge to Immunization Programmes /
|r M. Harboe --
|t Oral Delivery of Micro-Encapsulated DNA Vaccines /
|r D. H. Jones, J. C. S. Clegg and G. H. Farrar --
|t Nucleic Acid Vaccines Against Hepatitis Viruses /
|r C. R. Howard, L. Gray and F. D'Mello [et al.] --
|t Immune Responses Against Hepatitis C Virus Structural Proteins Following Genetic Immunisation /
|r G. Inchauspe, M. E. Major and I. Nakano [et al.] --
|t Induction of a TH1 Type Cellular Immune Response to the Human Immunodeficiency Type 1 Virus by in Vivo DNA Inoculation /
|r J. Boyer, K. Ugen and B. Wang [et al.] --
|t Rapporteur's Summary /
|r M. Liu --
|t The Effect of IL-12 Treatment on Vaccine-Enhanced Illness During Infection with Respiratory Syncytial Virus /
|r P. J. Openshaw and T. Hussell --
|t Rapporteur's Summary /
|r P. Beverley --
|t Antigen-Independent Activation of Resting T-Cells in the Liver of Patients with Chronic Hepatitis /
|r S. Abrignani --
|t A Novel Method for Enhancement of T Independent Responses /
|r P. Dullforce, D. Sutton and A. W. Heath --
|t Cytotoxic Activity Induced by Mycobacterium bovis BCG /
|r M. Gheorghiu, M. Lagranderie and A. M. Balazuc [et al.] --
|t The Role of Cytotoxic T-Cells in HIV Infection /
|r S. Rowland-Jones, T. Dong and P. Krausa [et al.] --
|t Rapporteur's Summary /
|r J.-L. Virelizier and S. Rowland-Jones --
|t Immunopotentiating Reconstituted Influenza Virosomes as a Novel Antigen Delivery System /
|r S. J. Cryz, Jr. and R. Gluck --
|t Protective Mucosal Immunity Elicited by Targeted Lymph Node Immunization with a Subunit SIV Envelope and Core Vaccine in Macaques /
|r T. Lehner, Y. Wang and M. Cranage [et al.] --
|t Rapporteur's Summary /
|r J. Robertson --
|t Adjuvants Perspectives /
|r E. R. Vogel --
|t Rapporteur's Summary /
|r J. Robertson --
|t Prevention of Rotavirus Diarrhoea in Foals by Parenteral Vaccination of the Mares: Field Trial /
|r M. Barrandeguy, V. Parreno and M. Lagos Marmol [et al.] --
|t Modulation of the Immune Response to Tetanus Toxoid by Polylactide-Polyglycolide Microspheres /
|r K. B. Walker, D. K.-L. Xing and D. Sesardic [et al.] --
|t Influence of Several Adjuvants on the Immune Response Against a Recombinant Meningococcal High Molecular Weight Antigen /
|r S. Gonzalez, C. Nazabal and L. Vina [et al.] --
|t Development of an Animal Model to Assess the Immunogenicity of Single-dose Tetanus and Diphtheria Vaccines Based on Controlled Release from Biodegradable Polymer Microspheres /
|r R. K. Gupta, P. Griffin, Jr. and R. Rivera [et al.] --
|t Kinetics Localization and Characteristics of B- and T-Cell Responses to Iscoms Containing Human Influenza Virus Glycoproteins /
|r M. Johansson, K. Lovgren-Bengtsson and A. Sjolander [et al.] --
|t In Vitro Determination of Antigen Quality: Biosensor Analysis and Fluorescence Spectroscopy /
|r G. F. A. Kersten, W. Jiskoot and T. Hazendonk [et al.] --
|t Immunity Provided by Haemorrhagic Septicaemia-Subunit Vaccine in Ruminants /
|r F. S. Maslog --
|t Cellular Immune Responses of Cattle to Cowdria ruminantium /
|r D. M. Mwangi, D. J. McKeever and S. M. Mahan --
|t Salivary Immune Responses after Gingival Immunization with Tetravaccinal and Bivaccinal Formulations of Inactivated Micro-Organisms /
|r P. Casetta and F. Negretti --
|t Effect of Aluminium Hydroxide and Meningococcal Serogroup C Capsular Polysaccharide on the Immunogenicity and Reactogenicity of a Group B Neisseria meningitidis Outer Membrane Vesicle Vaccine /
|r E. Rosenqvist, E. A. Hoiby and G. Bjune [et al.] --
|t Humoral Response to HSV-1 Subunit Vaccines - A Statistical Analysis /
|r J. R. Simms, A. W. Heath and V. J. Richardson [et al.] --
|t Systemic Development of a Block Copolymer Adjuvant for Trivalent Influenza Virus Vaccine /
|r C. W. Todd, E. Lee and M. Balusubramanian [et al.] --
|t Ovalbumin Coupled Either with Murine Red Blood Cells or Liposome Induces IgG but not IgE Antibody Production /
|r T. Uchida, S. Naito and A. Horino [et al.].
|
583 |
1 |
|
|a committed to retain
|c 20170930
|d 20421213
|f HathiTrust
|5 ICU
|
650 |
|
0 |
|a Vaccines
|x Standards
|v Congresses.
|
650 |
|
0 |
|a Immune response
|x Regulation
|v Congresses.
|0 http://id.loc.gov/authorities/subjects/sh2008104306
|
650 |
|
0 |
|a Immunological adjuvants
|v Congresses.
|
650 |
|
7 |
|a Immune response
|x Regulation.
|2 fast
|0 http://id.worldcat.org/fast/fst00967872
|
650 |
|
7 |
|a Immunological adjuvants.
|2 fast
|0 http://id.worldcat.org/fast/fst00967992
|
650 |
|
7 |
|a Vaccines
|x Standards.
|2 fast
|0 http://id.worldcat.org/fast/fst01163586
|
655 |
|
7 |
|a Conference papers and proceedings.
|2 fast
|0 http://id.worldcat.org/fast/fst01423772
|
700 |
1 |
|
|a Brown, Fred,
|d 1925-
|1 http://viaf.org/viaf/71452175
|
901 |
|
|
|a ToCBNA
|
903 |
|
|
|a HeVa
|
903 |
|
|
|a Hathi
|
929 |
|
|
|a cat
|
999 |
f |
f |
|i 5a594eb9-e059-5216-93c2-35abd2d46b22
|s b0aba943-6513-5f80-9ee7-548c0f863867
|
928 |
|
|
|t Library of Congress classification
|a QR189.M63 1998
|l ASR
|c ASR-SciASR
|i 3075897
|
927 |
|
|
|t Library of Congress classification
|a QR189.M63 1998
|l ASR
|c ASR-SciASR
|e CRERAR
|b 49227830
|i 5281350
|